Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?
Krag
Aleksander
A
Bendtsen
Flemming
F
Møller
Søren
S
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001201:Ascites / Q000188:drug therapy* / Q000401:mortality; D002302:Cardiac Output / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000401:mortality; D011433:Propranolol / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol